Brown Brothers Harriman & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-207
| Closed | -$38 | – | 1250 |
|
2021
Q2 | $38 | Sell |
207
-50
| -19% | -$9 | ﹤0.01% | 718 |
|
2021
Q1 | $39 | Buy |
257
+10
| +4% | +$2 | ﹤0.01% | 684 |
|
2020
Q4 | $39K | Buy |
247
+207
| +518% | +$32.7K | ﹤0.01% | 701 |
|
2020
Q3 | $5K | Hold |
40
| – | – | ﹤0.01% | 832 |
|
2020
Q2 | $4K | Buy |
40
+5
| +14% | +$500 | ﹤0.01% | 858 |
|
2020
Q1 | $3K | Sell |
35
-293
| -89% | -$25.1K | ﹤0.01% | 902 |
|
2019
Q4 | $35K | Sell |
328
-872
| -73% | -$93K | ﹤0.01% | 725 |
|
2019
Q3 | $118K | Hold |
1,200
| – | – | ﹤0.01% | 518 |
|
2019
Q2 | $157K | Buy |
1,200
+1,127
| +1,544% | +$147K | ﹤0.01% | 434 |
|
2019
Q1 | $10K | Buy |
+73
| New | +$10K | ﹤0.01% | 846 |
|
2018
Q3 | – | Sell |
-100
| Closed | -$12K | – | 912 |
|
2018
Q2 | $12K | Sell |
100
-175
| -64% | -$21K | ﹤0.01% | 647 |
|
2018
Q1 | $31K | Buy |
275
+50
| +22% | +$5.64K | ﹤0.01% | 524 |
|
2017
Q4 | $27K | Buy |
+225
| New | +$27K | ﹤0.01% | 604 |
|
2017
Q2 | – | Sell |
-72
| Closed | -$9K | – | 837 |
|
2017
Q1 | $9K | Sell |
72
-278
| -79% | -$34.8K | ﹤0.01% | 674 |
|
2016
Q4 | $43K | Buy |
+350
| New | +$43K | ﹤0.01% | 508 |
|
2016
Q3 | – | Sell |
-6
| Closed | -$1K | – | 839 |
|
2016
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 815 |
|
2016
Q1 | $1K | Sell |
6
-176
| -97% | -$29.3K | ﹤0.01% | 667 |
|
2015
Q4 | $35K | Sell |
182
-17
| -9% | -$3.27K | ﹤0.01% | 501 |
|
2015
Q3 | $31K | Buy |
199
+21
| +12% | +$3.27K | ﹤0.01% | 551 |
|
2015
Q2 | $32K | Hold |
178
| – | – | ﹤0.01% | 548 |
|
2015
Q1 | $31K | Buy |
178
+50
| +39% | +$8.71K | ﹤0.01% | 560 |
|
2014
Q4 | $24K | Buy |
+128
| New | +$24K | ﹤0.01% | 617 |
|
2014
Q2 | – | Sell |
-21
| Closed | -$3K | – | 828 |
|
2014
Q1 | $3K | Buy |
+21
| New | +$3K | ﹤0.01% | 741 |
|
2013
Q4 | – | Sell |
-17
| Closed | -$2K | – | 721 |
|
2013
Q3 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 663 |
|